AI assistant
WESTLAKE CORP — Director's Dealing 2014
Mar 3, 2014
30551_dirs_2014-03-03_c25529f5-4621-4b44-bd81-72023ce31e47.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WESTLAKE CHEMICAL CORP (WLK)
CIK: 0001262823
Period of Report: 2014-02-28
Reporting Person: RILEY H JOHN JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-28 | Common Stock | M | 3549 | $24.51 | Acquired | 12355 | Direct |
| 2014-02-28 | Common Stock | M | 3826 | $20.825 | Acquired | 16181 | Direct |
| 2014-02-28 | Common Stock | S | 7375 | $134.7047 | Disposed | 8806 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-02-28 | Employee Option (right to buy) | $24.51 | M | 3549 | Disposed | 2019-08-20 | Common Stock (3549) | Direct |
| 2014-02-28 | Employee Option (right to buy) | $20.825 | M | 3826 | Disposed | 2018-08-25 | Common Stock (3826) | Direct |
Footnotes
F1: The stock options are exercisable in three installments of 33%, 33% and 34% on August 20, 2010, 2011 and 2012, respectively.
F2: The stock options are exercisable in three installments of 33%, 33% and 34% on August 15, 2009, 2010 and 2011, respectively.
F3: In accordance with the Securities and Exchange Commission's No Action Letter dated June 25, 2008, we have aggregated the sales that occurred on February 28, 2014 for ease of reporting. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $134.678 to $134.84, inclusive. The reporting person undertakes to provide to Westlake Chemical Corporation, any security holder of Westlake Chemical Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.